Autres langues Simulations Plus, Inc.

Actions

SLP

US8292141053

Equipement et technologie médicale avancés

Temps réel estimé Cboe BZX 18:57:35 03/09/2026			Varia. 5j.	Varia. 1 janv.
18,44 ^USD	+0,08%		+0,19%	+1,23%

20/08	Le secteur pharmaceutique mise massivement sur l'IA dans l'espoir de réduire les coûts et les délais	RE
09/07	Simulations Plus : repli du bénéfice ajusté au troisième trimestre fiscal malgré une hausse du chiffre d'affaires	MT

Autres langues

20/08	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
13/08	Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
30/07	Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
09/07	Simulations Plus: Fiscal Q3 Earnings Snapshot
09/07	Simulations Plus Fiscal Q3 Adjusted Earnings Decline, Revenue Rises
09/07	Tranche Update on Simulations Plus, Inc.'s Equity Buyback Plan announced on January 4, 2023.
09/07	Simulations Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2026
09/07	Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
06/07	Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell Microcap Value Benchmark Index
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 2000 Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) dropped from Russell 2000 Growth-Defensive Index
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) dropped from Russell 2000 Defensive Index
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 3000E Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 3000 Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell Small Cap Comp Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 2500 Value Benchmark
23/06	Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit
22/06	Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
18/06	Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
16/06	SLP Stock Alert: Halper Sadeh LLC is Investigating Whether Simulations Plus, Inc. is Obtaining a Fair Price for its Shareholders
16/06	Simulations Plus to Be Acquired by Altaris in $375 Million All-Cash Deal
09/06	Simulations Plus (SLP) Securities Investigation: Johnson Fistel Reviews Revenue Guidance Cut, $77.2M Impairment Charge, and Auditor Dispute
03/06	Simulations Plus, Inc. (SLP) Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Guidance Cut, Impairment Charge, and Auditor Dispute
02/06	Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute